Evidence map›Paper›PMID 18775783›Full record

ArticleMolecular and cellular neurosciences2008

Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes.

T M Maynard, D W Meechan, M L Dudevoir, D Gopalakrishna, A Z Peters, C C Heindel, T J Sugimoto, Y Wu, J A Lieberman, A-S Lamantia

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular neurosciences, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 143 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Mitochondrial Oxidative Phosphorylation System Dysfunction in Schizophrenia.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Brain and behavioural anomalies caused byLife science alliance · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. MAVS Cys508 palmitoylation promotes its aggregation on the mitochondrial outer membrane and antiviral innate immunity.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

T M MaynardDepartment of Cell and Molecular Physiology, The University of North Carolina School of Medicine, Chapel Hill, NC 27599-7545, USA.
D W Meechan
M L Dudevoir
D Gopalakrishna
A Z Peters
C C Heindel
T J Sugimoto
Y Wu
J A Lieberman
A-S Lamantia
University of North Carolina at Chapel Hill · US

Funding

Prospective study of the onset of schizophreniaP50MH064065 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GILMORE, JOHN HORACE · 2002 to 2011
$19.6M
UNC Neuroscience Center Research Cores: MicroscopyP30NS045892 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZYLKA, MARK J. · 2003 to 2022
$11.5M
Regulation of 22q11 Genes in Embryonic and Adult ForebrainR01HD042182 · NICHD · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI ANTHONY S LAMANTIA · 2003 to 2026
$8.6M
Roles of Growth Factor Signaling in Neural RegenerationR01NS031768 · NINDS · WASHINGTON UNIVERSITY · PI SNIDER, WILLIAM D · 1993 to 2016
$6.7M
Specification of Peripheral Olfactory Stem CellsR01DC011534 · NIDCD · GEORGE WASHINGTON UNIVERSITY · PI LAMANTIA, ANTHONY S · 2011 to 2015
$1.7M
UNC Developmental Biology Training ProgramT32HD046369 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAGNUSON, TERRY R · 2005 to 2009
$1.4M
NICHD NIH HHS HD42182NICHD NIH HHS R01 HD042182NICHD NIH HHS T32 HD046369NIDCD NIH HHS R01 DC011534NIMH NIH HHS P50 MH064065NINDS NIH HHS P30 NS045892NINDS NIH HHS R01 NS031768
6 · The paper itself

Abstract

Six genes in the 1.5 Mb region of chromosome 22 deleted in DiGeorge/22q11 deletion syndrome-Mrpl40, Prodh, Slc25a1, Txnrd2, T10, and Zdhhc8-encode mitochondrial proteins. All six genes are expressed in the brain, and maximal expression coincides with peak forebrain synaptogenesis shortly after birth. Furthermore, their protein products are associated with brain mitochondria, including those in synaptic terminals. Among the six, only Zddhc8 influences mitochondria-regulated apoptosis when overexpressed, and appears to interact biochemically with established mitochondrial proteins. Zdhhc8 has an apparent interaction with Uqcrc1, a component of mitochondrial complex III. The two proteins are coincidently expressed in pre-synaptic processes; however, Zdhhc8 is more frequently seen in glutamatergic terminals. 22q11 deletion may alter metabolic properties of cortical mitochondria during early post-natal life, since expression complex III components, including Uqcrc1, is significantly increased at birth in a mouse model of 22q11 deletion, and declines to normal values in adulthood. Our results suggest that altered dosage of one, or several 22q11 mitochondrial genes, particularly during early post-natal cortical development, may disrupt neuronal metabolism or synaptic signaling.

Indexed as

Chromosome DeletionAcyltransferasesAnimalsBrainCells, CulturedChromosomes, Human, Pair 22Computational BiologyDiGeorge SyndromeFibroblastsHumansMembrane ProteinsMiceMitochondriaMitochondrial ProteinsRecombinant Fusion ProteinsSynapsesAcyltransferasesMembrane ProteinsMitochondrial ProteinsRecombinant Fusion ProteinsZDHHC8 protein, mouse

Identifiers

PMID18775783
PMCPMC2729512
OpenAlexW2086020590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.